Acadia Pharmaceuticals 2024 Proxy Statement Annual Meeting

Acadia Pharmaceuticals' 2024 proxy statement and notice of annual meeting of stockholders held virtually on May 29, 2024. The document covers election of three Class II directors, advisory vote on executive compensation, approval of the 2024 Equity Incentive Plan, and ratification of Ernst & Young LLP as independent auditor.